242 related articles for article (PubMed ID: 16202646)
1. Hepatitis C as a metabolic disease: Implication for the pathogenesis of NASH.
Koike K
Hepatol Res; 2005 Oct; 33(2):145-50. PubMed ID: 16202646
[TBL] [Abstract][Full Text] [Related]
2. Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection.
Koike K
J Gastroenterol; 2009; 44 Suppl 19():82-8. PubMed ID: 19148799
[TBL] [Abstract][Full Text] [Related]
3. Animal models for hepatitis C and related liver disease.
Koike K; Moriya K; Matsuura Y
Hepatol Res; 2010 Jan; 40(1):69-82. PubMed ID: 20156300
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance.
Shintani Y; Fujie H; Miyoshi H; Tsutsumi T; Tsukamoto K; Kimura S; Moriya K; Koike K
Gastroenterology; 2004 Mar; 126(3):840-8. PubMed ID: 14988838
[TBL] [Abstract][Full Text] [Related]
5. Metabolic aspects of hepatitis C viral infection: steatohepatitis resembling but distinct from NASH.
Koike K; Moriya K
J Gastroenterol; 2005 Apr; 40(4):329-36. PubMed ID: 15868369
[TBL] [Abstract][Full Text] [Related]
6. NAFLD and NASH in HCV Infection: Prevalence and Significance in Hepatic and Extrahepatic Manifestations.
Adinolfi LE; Rinaldi L; Guerrera B; Restivo L; Marrone A; Giordano M; Zampino R
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231906
[TBL] [Abstract][Full Text] [Related]
7. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C.
Miquilena-Colina ME; Lima-Cabello E; Sánchez-Campos S; García-Mediavilla MV; Fernández-Bermejo M; Lozano-Rodríguez T; Vargas-Castrillón J; Buqué X; Ochoa B; Aspichueta P; González-Gallego J; García-Monzón C
Gut; 2011 Oct; 60(10):1394-402. PubMed ID: 21270117
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase.
Tanaka N; Nagaya T; Komatsu M; Horiuchi A; Tsuruta G; Shirakawa H; Umemura T; Ichijo T; Matsumoto A; Yoshizawa K; Aoyama T; Kiyosawa K; Tanaka E
Liver Int; 2008 Sep; 28(8):1104-11. PubMed ID: 18397231
[TBL] [Abstract][Full Text] [Related]
9. Tacrolimus ameliorates metabolic disturbance and oxidative stress caused by hepatitis C virus core protein: analysis using mouse model and cultured cells.
Moriya K; Miyoshi H; Tsutsumi T; Shinzawa S; Fujie H; Shintani Y; Yotsuyanagi H; Moriishi K; Matsuura Y; Suzuki T; Miyamura T; Koike K
Am J Pathol; 2009 Oct; 175(4):1515-24. PubMed ID: 19729476
[TBL] [Abstract][Full Text] [Related]
10. Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight.
Ballestri S; Nascimbeni F; Romagnoli D; Baldelli E; Targher G; Lonardo A
Int J Mol Sci; 2016 Mar; 17(3):355. PubMed ID: 27005620
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
[TBL] [Abstract][Full Text] [Related]
12. NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome.
Chitturi S; Abeygunasekera S; Farrell GC; Holmes-Walker J; Hui JM; Fung C; Karim R; Lin R; Samarasinghe D; Liddle C; Weltman M; George J
Hepatology; 2002 Feb; 35(2):373-9. PubMed ID: 11826411
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.
Dai CY; Yeh ML; Huang CF; Hou CH; Hsieh MY; Huang JF; Lin IL; Lin ZY; Chen SC; Wang LY; Chuang WL; Yu ML; Tung HD
J Gastroenterol Hepatol; 2015 May; 30(5):879-84. PubMed ID: 23808794
[TBL] [Abstract][Full Text] [Related]
14. Extrahepatic Manifestations of Chronic Hepatitis C Virus (HCV) Infection.
Garg B; Arbabi A; Kirkland PA
Cureus; 2024 Mar; 16(3):e57343. PubMed ID: 38562366
[TBL] [Abstract][Full Text] [Related]
15. Extrahepatic Manifestations of Hepatitis C: A Meta-analysis of Prevalence, Quality of Life, and Economic Burden.
Younossi Z; Park H; Henry L; Adeyemi A; Stepanova M
Gastroenterology; 2016 Jun; 150(7):1599-1608. PubMed ID: 26924097
[TBL] [Abstract][Full Text] [Related]
16. Hepatic insulin resistance is associated with increased apoptosis and fibrogenesis in nonalcoholic steatohepatitis and chronic hepatitis C.
García-Monzón C; Lo Iacono O; Mayoral R; González-Rodríguez A; Miquilena-Colina ME; Lozano-Rodríguez T; García-Pozo L; Vargas-Castrillón J; Casado M; Boscá L; Valverde AM; Martín-Sanz P
J Hepatol; 2011 Jan; 54(1):142-52. PubMed ID: 20888662
[TBL] [Abstract][Full Text] [Related]
17. Verification of B-lymphocyte activating factor's involvement in the exacerbation of insulin resistance as well as an autoimmune response in patients with nonalcoholic steatohepatitis and patients with HCV-related chronic liver disease.
Himoto T; Fujita K; Nomura T; Tani J; Morishita A; Yoneyama H; Haba R; Masaki T
Diabetol Metab Syndr; 2017; 9():45. PubMed ID: 28630652
[TBL] [Abstract][Full Text] [Related]
18. Non-alcoholic fatty liver disease and hepatitis C infection.
Bondini S; Younossi ZM
Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
[TBL] [Abstract][Full Text] [Related]
19. Systematic review: chronic viral hepatitis and metabolic derangement.
Wang CC; Cheng PN; Kao JH
Aliment Pharmacol Ther; 2020 Jan; 51(2):216-230. PubMed ID: 31746482
[TBL] [Abstract][Full Text] [Related]
20. Metabolic alterations and hepatitis C: From bench to bedside.
Chang ML
World J Gastroenterol; 2016 Jan; 22(4):1461-76. PubMed ID: 26819514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
